Following on from the recent news in February 2023 that Duke NUS and NHCS scientists found that blocking an immune regulating protein Interleukin-11 (IL-11) can stop and even reverse kidney damage caused by acute and chronic kidney disease in mouse models Boehringer Ingelheim (Pharma company) have announced they are starting clinical development on an IL-11 Inhibitor with a Phase 1 study.
This is only shown so far in mouse models. But if this proves successful in clinical development it appears we could regenerate already damaged kidneys to some degree.
Absolutely correct Coach if by then…the breakthroughs are tremendous but the process of implanting anything resembling a God-Crafted (my personal belief doesn’t have to be yours) kidney is currently beyond the working knowledge or at least the conceptual thinking of current research. Don’t misunderstand my point, I am grateful for the progress as the younger generations my kids age will most likely benefit from the leaps being made now but I do t believe that’s in the cards for us!
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.